deltatrials
Unknown PHASE2 INTERVENTIONAL 2-arm NCT02066571

Study to Assess the Clinical Benefit and Safety of Droxidopa in Parkinson's Disease

A Phase II, Double-Blind, Placebo-Controlled, Crossover Study to Assess Clinical Benefit and Safety of Droxidopa in the Treatment of Parkinson's Disease

Sponsor: Henry Ford Health System

Conditions Cognitive Ability, General Freezing of Gait Parkinson's Disease
Interventions Droxidopa sugar pill
Updated 7 times since 2017 Last updated: Nov 2, 2016 Started: Mar 31, 2015 Primary completion: Apr 30, 2017 Completion: Dec 31, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Cognitive Ability, General and Freezing of Gait and is currently ongoing. Henry Ford Health System leads this study, which shows 7 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotEnrolling By Invitation~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotEnrolling By Invitation~Jun 2018 – ~Dec 2018 · 6 months · monthly snapshotEnrolling By Invitation~Dec 2018 – ~Jan 2021 · 25 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE2

  4. Dec 2018 — Jan 2021 [monthly]

    Unknown Status PHASE2

    Status: Enrolling By Invitation → Unknown Status

  5. Jun 2018 — Dec 2018 [monthly]

    Enrolling By Invitation PHASE2

▶ Show 2 earlier versions

  1. Feb 2017 — Jun 2018 [monthly]

    Enrolling By Invitation PHASE2

  2. Jan 2017 — Feb 2017 [monthly]

    Enrolling By Invitation PHASE2

    First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Henry Ford Health System
Data source: Henry Ford Health System

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations